EUVIMEDEUVIMED entdecken
Crossref

"Factor VIII inhibitors – Results of immunotolerance induction at the National Haemophilia Centre; new options and first experience with treatment using a bispecific antibody (emicizumab) in patients with inhibitors in Slovakia"

Angelika Bátorová, Tatiana Prigancová, Denisa Jankovičová, Anna Kyselová

Transfuze a hematologie dnes · 2021

DOI: 10.48095/cctahd202163 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfuze a hematologie dnes, 2021. Verfasst von Angelika Bátorová und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Bátorová, A., Prigancová, T., Jankovičová, D., & Kyselová, A. (2021). "Factor VIII inhibitors – Results of immunotolerance induction at the National Haemophilia Centre; new options and first experience with treatment using a bispecific antibody (emicizumab) in patients with inhibitors in Slovakia". Transfuze a hematologie dnes. https://doi.org/10.48095/cctahd202163

Vancouver

Bátorová A, Prigancová T, Jankovičová D, Kyselová A. "Factor VIII inhibitors – Results of immunotolerance induction at the National Haemophilia Centre; new options and first experience with treatment using a bispecific antibody (emicizumab) in patients with inhibitors in Slovakia". Transfuze a hematologie dnes. 2021. doi:10.48095/cctahd202163

BibTeX
@article{Btorov2021,
  author = {Bátorová, Angelika and Prigancová, Tatiana and Jankovičová, Denisa and Kyselová, Anna},
  title = {"Factor VIII inhibitors – Results of immunotolerance induction at the National Haemophilia Centre; new options and first experience with treatment using a bispecific antibody (emicizumab) in patients with inhibitors in Slovakia"},
  journal = {Transfuze a hematologie dnes},
  year = {2021},
  doi = {10.48095/cctahd202163}
}
Kostenlos starten →